Literature DB >> 15639193

Functional characterization of the K257R and G319E-hGALE alleles found in patients with ostensibly peripheral epimerase deficiency galactosemia.

Jamie Wasilenko1, Mary E Lucas, James B Thoden, Hazel M Holden, Judith L Fridovich-Keil.   

Abstract

Epimerase deficiency galactosemia is an autosomal recessive condition resulting from the impairment of UDP-galactose 4'-epimerase (hGALE). Although a small number of clinically severe patients have been reported who exhibit "generalized" GALE deficiency, the vast majority exhibit an apparently benign "peripheral" form of the disorder in which enzyme impairment is restricted to the circulating red and white blood cells. Previously, preliminary data were reported suggesting that GALE deficiency is 10-fold more common among African-Americans than among non-African-Americans, and that two missense mutations, K257R and G319E, are found in at least some of these patients. We report here functional studies of these alleles involving expression of the substituted human enzymes in a null-background strain of yeast. Although under normal assay conditions both substituted proteins demonstrate enzyme activities indistinguishable from the wild-type, one (G319E) demonstrates mild impairment under conditions of substrate limitation. No impairments are evident under conditions of cofactor (NAD) limitation. These results are consistent with the apparently benign status of peripheral epimerase deficiency galactosemia, but leave open the question of why patients with these substitutions demonstrate GALE deficiency in their red blood cells. While the possibility remains that K257R and G319E may cause tissue-specific impairments not recapitulated in vitro or in yeast, an equally if not more plausible explanation suggested by interspecies sequence alignments is that both substitutions may be polymorphisms that exist in linkage disequilibrium with other, as yet unidentified causal mutations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15639193     DOI: 10.1016/j.ymgme.2004.09.003

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  11 in total

1.  Altered cofactor binding affects stability and activity of human UDP-galactose 4'-epimerase: implications for type III galactosemia.

Authors:  Thomas J McCorvie; Ying Liu; Andrew Frazer; Tyler J Gleason; Judith L Fridovich-Keil; David J Timson
Journal:  Biochim Biophys Acta       Date:  2012-05-18

2.  A Case of UDP-Galactose 4'-Epimerase Deficiency Associated with Dyshematopoiesis and Atrioventricular Valve Malformations: An Exceptional Clinical Phenotype Explained by Altered N-Glycosylation with Relative Preservation of the Leloir Pathway.

Authors:  Christopher A Febres-Aldana; Liset Pelaez; Meredith S Wright; Ossama M Maher; Anthony J Febres-Aldana; Jun Sasaki; Parul Jayakar; Anuj Jayakar; Magaly Diaz-Barbosa; Michelin Janvier; Bala Totapally; Daria Salyakina; Jorge R Galvez-Silva
Journal:  Mol Syndromol       Date:  2020-10-29

3.  Galactose Epimerase Deficiency: Expanding the Phenotype.

Authors:  Filipa Dias Costa; Sacha Ferdinandusse; Carla Pinto; Andrea Dias; Liesbeth Keldermans; Dulce Quelhas; Gert Matthijs; Petra A Mooijer; Luísa Diogo; Jaak Jaeken; Paula Garcia
Journal:  JIMD Rep       Date:  2017-03-01

4.  Developmental defects in a Caenorhabditis elegans model for type III galactosemia.

Authors:  Ana M Brokate-Llanos; José M Monje; Piedad Del Socorro Murdoch; Manuel J Muñoz
Journal:  Genetics       Date:  2014-10-08       Impact factor: 4.562

5.  Epimerase-deficiency galactosemia is not a binary condition.

Authors:  Kimberly K Openo; Jenny M Schulz; Claudia A Vargas; Corey S Orton; Michael P Epstein; Rhonda E Schnur; Fernando Scaglia; Gerard T Berry; Gary S Gottesman; Can Ficicioglu; Alfred E Slonim; Richard J Schroer; Chunli Yu; Vanessa E Rangel; Jennifer Keenan; Kerri Lamance; Judith L Fridovich-Keil
Journal:  Am J Hum Genet       Date:  2005-11-14       Impact factor: 11.025

6.  Distinct roles of galactose-1P in galactose-mediated growth arrest of yeast deficient in galactose-1P uridylyltransferase (GALT) and UDP-galactose 4'-epimerase (GALE).

Authors:  Jane Odhiambo Mumma; Juliet S Chhay; Kerry L Ross; Jana S Eaton; Karen A Newell-Litwa; Judith L Fridovich-Keil
Journal:  Mol Genet Metab       Date:  2007-11-05       Impact factor: 4.797

7.  Inherited thrombocytopenia associated with mutation of UDP-galactose-4-epimerase (GALE).

Authors:  Aaron Seo; Suleyman Gulsuner; Sarah Pierce; Miri Ben-Harosh; Hanna Shalev; Tom Walsh; Tanya Krasnov; Orly Dgany; Sergei Doulatov; Hannah Tamary; Akiko Shimamura; Mary-Claire King
Journal:  Hum Mol Genet       Date:  2019-01-01       Impact factor: 6.150

8.  Analysis of UDP-galactose 4'-epimerase mutations associated with the intermediate form of type III galactosaemia.

Authors:  J S Chhay; C A Vargas; T J McCorvie; J L Fridovich-Keil; D J Timson
Journal:  J Inherit Metab Dis       Date:  2008-01-14       Impact factor: 4.982

9.  In vivo and in vitro function of human UDP-galactose 4'-epimerase variants.

Authors:  Thomas J McCorvie; Jamie Wasilenko; Ying Liu; Judith L Fridovich-Keil; David J Timson
Journal:  Biochimie       Date:  2011-06-17       Impact factor: 4.079

Review 10.  Galactosemia: Biochemistry, Molecular Genetics, Newborn Screening, and Treatment.

Authors:  Mariangela Succoio; Rosa Sacchettini; Alessandro Rossi; Giancarlo Parenti; Margherita Ruoppolo
Journal:  Biomolecules       Date:  2022-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.